Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients
- 28 March 2012
- journal article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 20 (12), 3129-3135
- https://doi.org/10.1007/s00520-012-1444-5
Abstract
Inflammatory, angiogenic and oxidative stress markers have been explored in head and neck squamous cell carcinoma (HNSCC) patients before and during radiochemotherapy. Furthermore, the effects of an oral supplementation containing amino acids, ω-3 fatty acids, ribonucleic acids, vitamins, and antioxidants on biological markers and acute toxicities were investigated. Thirty-one patients with non-metastatic stage III or IV HNSCC treated with concomitant radiochemotherapy were recruited. A nutritional support (Oral Impact®) was given during 5 days before each cycle of chemotherapy. Biological samples were collected at baseline, after 5 days of oral supplementation and before the last cycle of chemotherapy. Acute phase proteins levels, proteomic cytokines determination and urinary isoprostanes levels were used as inflammatory and oxidative stress biomarkers. Toxicities were followed up during radiochemotherapy. At baseline, median levels of inflammatory (CRP 9.8 mg/l [0.8–130.1], IL-6 4.2 pg/ml [0.7–126.5]), pro-angiogenic (VEGF 229.5 pg/ml [13.1–595.9]) and pro-oxidative stress (urinary isoprostanes 118 pmol/mmol creatinine [51–299]) markers were increased. Decrease in CRP (p = 0.002) and α-1 acid glycoprotein (p = 0.020) levels were observed after 5 days of oral supplementation. During radiochemotherapy, no significant variation of inflammatory markers was reported, and a low incidence of severe acute mucositis was noted. Stage III or IV HNSCC patients are characterised by a pro-inflammatory, pro-angiogenic and pro-oxidative status. Nutritional support could improve this inflammatory state and could prevent severe acute mucositis.Keywords
This publication has 42 references indexed in Scilit:
- Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot studyRadiation Oncology, 2010
- Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapySupportive Care in Cancer, 2009
- Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography–mass spectrometry (GC-MS) methodFree Radical Biology & Medicine, 2009
- Current and potential inflammation targeted therapies in head and neck cancerCurrent Opinion in Pharmacology, 2009
- Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2008
- Fine-Tuning of the Prediction of Mortality in Hemodialysis Patients by Use of Cytokine Proteomic DeterminationClinical Journal of the American Society of Nephrology, 2008
- Relationship between Urinary 15-F2t-Isoprostane and 8-Oxodeoxyguanosine Levels and Breast Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2006
- Immunoenhanced enteral nutrition, effect on inflammatory markers in head and neck cancer patientsEuropean Journal of Clinical Nutrition, 2004
- Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinomaInternational Journal of Oral & Maxillofacial Surgery, 2002
- Early Enteral Nutrition in Critically III Patients With a High‐Protein Diet Enriched with Arginine, Fiber, and Antioxidants Compared With a Standard High‐Protein Diet. The Effect on Nosocomial Infections and OutcomeJournal of Parenteral and Enteral Nutrition, 2001